Hepatocellular carcinoma shows a strong, diffuse and granular expression of hepatocyte specific antigen.
Hepatocyte Specific Antigen (Hep Par-1) (OCH1E5) Mouse Monoclonal Antibody
Specialties: Anatomic Pathology Gastrointestinal (GI) Pathology
Updated: 2022-09-09 14:06:24
Anti-hepatocyte specific antigen, also known as anti-Hep-Par1 (hepatocyte paraffin 1), recognizes both benign and malignant liver-derived tissues including such tumors as hepatocellular carcinoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in identifying hepatocellular carcinomas.1-5
- Minervini, M I et al. "Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 10,7 (1997): 686-92.
- Chu, Peiguo G et al. "Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein." The American journal of surgical pathology vol. 26,8 (2002): 978-88.
- Wieczorek, Tad J et al. "Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma." American journal of clinical pathology vol. 118,6 (2002): 911-21.
- Fasano, M et al. "Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 11,10 (1998): 934-8.
- Maitra, A et al. "Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract." American journal of clinical pathology vol. 115,5 (2001): 689-94.
Specifications
- Reactivity: paraffin
- Control: Liver (Cytoplasmic)
- Dilution Range: 1:100-1:500 *
Package Inserts
IFU
- IVD Rev. 6.0 (CMC26429060)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 25.0 mL predilute ready-to-use | 264M-90 |
| 0.1 mL concentrate | 264M-94 |
| 0.5 mL concentrate | 264M-95 |
| 1.0 mL concentrate | 264M-96 |
| 1.0 mL predilute ready-to-use | 264M-97 |
| 7.0 mL predilute ready-to-use | 264M-98 |
For in vitro diagnostic (IVD) use in Canada
| 25.0 mL predilute ready-to-use | 264M-90 |
| 0.1 mL concentrate | 264M-94 |
| 0.5 mL concentrate | 264M-95 |
| 1.0 mL concentrate | 264M-96 |
| 1.0 mL predilute ready-to-use | 264M-97 |
| 7.0 mL predilute ready-to-use | 264M-98 |
For in vitro diagnostic (IVD) use in Europe
| 25.0 mL predilute ready-to-use | 264M-90 |
| 0.1 mL concentrate | 264M-94 |
| 0.5 mL concentrate | 264M-95 |
| 1.0 mL concentrate | 264M-96 |
| 1.0 mL predilute ready-to-use | 264M-97 |
| 7.0 mL predilute ready-to-use | 264M-98 |
For research use only (RUO) in Japan
| 25.0 mL predilute ready-to-use | 264M-90-RUO |
| 0.1 mL concentrate | 264M-94-RUO |
| 0.5 mL concentrate | 264M-95-RUO |
| 1.0 mL concentrate | 264M-96-RUO |
| 1.0 mL predilute ready-to-use | 264M-97-RUO |
| 7.0 mL predilute ready-to-use | 264M-98-RUO |
To request information on this product in additional countries, please click the button below.
